Omni Saúde offers a digital medication plan that provides coverage at all pharmacies in Brazil, sold to employers at an average cost of R$25 per employee. The company has sold more than 15,000 medication plans and aims to reach 50,000 lives and nearly R$10 million in annual revenue by the end of the year. Omni recently completed its third fundraising in under two years, raising R$16 million in a new round led by Norte Ventures with support from angel investors Jaime de Paula, Massanori Shibata Jr and Jorge Oliveira. The company plans to use the new capital to strengthen internal operations, optimize processes, expand its team and adopt advanced technologies. CEO and cofounder Fernando Domingues said the investment is essential to maintain leadership and meet growing market demand. With nationwide pharmacy coverage, Omni positions itself as an employer-focused alternative for medication benefits and intends to intensify growth with the new funding. Omni offers a pharmacy-agnostic digital medication plan for employers, with an average cost of R$25 per employee. The product is positioned to become an essential HR benefit across sectors and supports payment via PIX. Omni also promotes patient education on rational and safe medication use, adherence to treatment, and the dangers of self-medication. The company already serves corporate clients including Dasa, Spoleto, Alper Seguros, Qualicorp, Riachuelo, and Vitta/Stone. A new investment will be used to expand access to medicines and strengthen Omni's market position. Omni targets achieving R$1.5 million in monthly revenue by the end of the year.

Total raised

$5M

Funding rounds

2

Latest round

Equity

Latest activity

Aug 2024